U.S. insulin costs per patient nearly doubled from 2012 to 2016, study finds
The cost of insulin for treating Type 1 diabetes in the United States nearly doubled over a recent five-year period, underscoring a national outcry over rising drug prices, according to a new analysis.
A patient with Type 1 diabetes incurred annual insulin costs of $5,705, on average, in 2016. The average cost was roughly half that, at $2,864 per patient, in 2012, according to a report released on Tuesday by the nonprofit Health Care Cost Institute.
The figures represent the combined amount paid by a patient and their health plan for the medicine and do not reflect rebates paid at a later date.
(Score: 2) by dry on Thursday January 24 2019, @07:08AM
Basically how it works in Canada. The feds collects and distributes money, the Provinces (and Territories) run their healthcare according to the minimal guidelines from the feds. The Provinces also do some of the financing. As the feds can't force the Provinces to do healthcare, the carrot works well, along with the voters liking public healthcare.
Actually government healthcare started at the Provincial level, back when farmers often voted socialist, at least in the Provincial elections.